Cargando…

Development and Clinical Evaluation of Serum and Urine-Based Lateral Flow Tests for Diagnosis of Human Visceral Leishmaniasis

Visceral leishmaniasis (VL), a fatal parasitic infection, is categorized as being neglected among tropical diseases. The use of conventional tissue aspiration for diagnosis is not possible in every setting. The immunochromatography-based lateral flow assay (LFA) has attracted attention for a long ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ejazi, Sarfaraz Ahmad, Choudhury, Somsubhra Thakur, Bhattacharyya, Anirban, Kamran, Mohd, Pandey, Krishna, Das, Vidya Nand Ravi, Das, Pradeep, da Silva, Fernando Oliveira, Costa, Dorcas Lamounier, Costa, Carlos Henrique Nery, Rahaman, Mehebubar, Goswami, Rama Prosad, Ali, Nahid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305891/ https://www.ncbi.nlm.nih.gov/pubmed/34201902 http://dx.doi.org/10.3390/microorganisms9071369

Ejemplares similares

Immunoproteomic Identification and Characterization of Leishmania Membrane Proteins as Non-Invasive Diagnostic Candidates for Clinical Visceral Leishmaniasis
por: Ejazi, Sarfaraz Ahmad, et al.
Publicado: (2018)

Revealing a Novel Antigen Repressor of Differentiation Kinase 2 for Diagnosis of Human Visceral Leishmaniasis in India
por: Bhattacharyya, Anirban, et al.
Publicado: (2022)

Investigation of the antigenicity and protective efficacy of Leishmania promastigote membrane antigens in search of potential diagnostic and vaccine candidates against visceral leishmaniasis
por: Ejazi, Sarfaraz Ahmad, et al.
Publicado: (2020)

Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India
por: Ejazi, Sarfaraz Ahmad, et al.
Publicado: (2016)

Induction of IL-10 and TGFβ from CD4(+)CD25(+)FoxP3(+) T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovani
por: Bhattacharya, Pradyot, et al.
Publicado: (2016)

A multicentric evaluation of dipstick test for serodiagnosis of visceral leishmaniasis in India, Nepal, Sri Lanka, Brazil, Ethiopia and Spain
por: Ejazi, Sarfaraz Ahmad, et al.
Publicado: (2019)

Author Correction: A multicentric evaluation of dipstick test for serodiagnosis of visceral leishmaniasis in India, Nepal, Sri Lanka, Brazil, Ethiopia and Spain
por: Ejazi, Sarfaraz Ahmad, et al.
Publicado: (2021)

Easy Test for Visceral Leishmaniasis and Post–Kala-azar Dermal Leishmaniasis
por: Saha, Samiran, et al.
Publicado: (2011)

A Curative Immune Profile One Week after Treatment of Indian Kala-Azar Patients Predicts Success with a Short-Course Liposomal Amphotericin B Therapy
por: Mondal, Smriti, et al.
Publicado: (2010)

Detection of Leptomonas seymouri narna-like virus in serum samples of visceral leishmaniasis patients and its possible role in disease pathogenesis
por: Sukla, Soumi, et al.
Publicado: (2022)

Cutaneous parasitism in patients with American visceral leishmaniasis in an endemic area
por: Moura, Carla Riama Lopes de Pádua, et al.
Publicado: (2020)

Development of Immunological Assays Based on Leishmania donovani Antigen for Diagnosis of Canine Visceral Leishmaniasis and Their Multicenter Evaluation in Brazil and Italy
por: Ejazi, Sarfaraz Ahmad, et al.
Publicado: (2022)

Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis
por: Sabur, Abdus, et al.
Publicado: (2018)

Evidence map of diagnosis, treatment, prognosis, prevention, and control in visceral leishmaniasis
por: Ibiapina, Andressa Barros, et al.
Publicado: (2022)

Congenitally transmitted visceral leishmaniasis: report of two Brazilian human cases
por: Mescouto-Borges, Myrlena Regina Machado, et al.
Publicado: (2013)

Natural Resistance of Leishmania infantum to Miltefosine Contributes to the Low Efficacy in the Treatment of Visceral Leishmaniasis in Brazil
por: Carnielli, Juliana B. T., et al.
Publicado: (2019)

Impact of ASHA Training on Active Case Detection of Visceral Leishmaniasis in Bihar, India
por: Das, Vidya Nand Ravi, et al.
Publicado: (2014)

Clinical Severity of Visceral Leishmaniasis Is Associated with Changes in Immunoglobulin G Fc N-Glycosylation
por: Gardinassi, Luiz Gustavo, et al.
Publicado: (2014)

The pathogenicity and virulence of Leishmania - interplay of virulence factors with host defenses
por: Gupta, Anand Kumar, et al.
Publicado: (2022)

From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis
por: Costa, Carlos H. N., et al.
Publicado: (2023)

Lipoprotein Lipase and PPAR Alpha Gene Polymorphisms, Increased Very-Low-Density Lipoprotein Levels, and Decreased High-Density Lipoprotein Levels as Risk Markers for the Development of Visceral Leishmaniasis by Leishmania infantum
por: Carvalho, Márcia Dias Teixeira, et al.
Publicado: (2014)

Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study
por: Sundar, Shyam, et al.
Publicado: (2014)

Diagnosis of Visceral Leishmaniasis in Bihar India: Comparison of the rK39 Rapid Diagnostic Test on Whole Blood Versus Serum
por: Matlashewski, Greg, et al.
Publicado: (2013)

Parasite Genotype Is a Major Predictor of Mortality from Visceral Leishmaniasis
por: Grace, Cooper Alastair, et al.
Publicado: (2022)

Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India
por: Das, Vidya Nand Ravi, et al.
Publicado: (2016)

Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India
por: Goyal, Vishal, et al.
Publicado: (2020)

Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial
por: Romero, Gustavo Adolfo Sierra, et al.
Publicado: (2017)

Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers
por: Das, Vidya Nand Rabi, et al.
Publicado: (2020)

Immunity to Visceral Leishmaniasis
por: Ali, Nahid, et al.
Publicado: (2012)

Genetically Modified Organisms and Visceral Leishmaniasis
por: Chhajer, Rudra, et al.
Publicado: (2014)

Vesicular (liposomal and nanoparticulated) delivery of curcumin: a comparative study on carbon tetrachloride–mediated oxidative hepatocellular damage in rat model
por: Choudhury, Somsubhra Thakur, et al.
Publicado: (2016)

Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario
por: Pandey, Krishna, et al.
Publicado: (2009)

Toolkit for Monitoring and Evaluation of Indoor Residual Spraying for Visceral Leishmaniasis Control in the Indian Subcontinent: Application and Results
por: Huda, M. Mamun, et al.
Publicado: (2011)

Diagnostic antigens for visceral leishmaniasis: clarification of nomenclatures
por: Bhattacharyya, Tapan, et al.
Publicado: (2017)

A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India
por: Das, Vidya Nand Rabi, et al.
Publicado: (2009)

Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India
por: Goyal, Vishal, et al.
Publicado: (2019)

HIV, visceral leishmaniasis and Parkinsonism combined with diabetes mellitus and hyperuricaemia: A case report
por: Pandey, Krishna, et al.
Publicado: (2008)

Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis
por: Ravindran, Rajesh, et al.
Publicado: (2010)

A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis
por: Carnielli, Juliana B.T., et al.
Publicado: (2018)

Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India
por: Goyal, Vishal, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dtr04gkhnq6bqqc377b1ai0n4c